Health Catalyst, Inc. (FRA:2YP)
Germany
· Delayed Price · Currency is EUR 2.320
0.00 (0.00%)
At close: Dec 5, 2025
Health Catalyst Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
| Revenue | 316.06 | 306.58 | 295.94 | 276.24 | 241.93 | 188.85 | Upgrade
|
| Revenue Growth (YoY) | 4.63% | 3.60% | 7.13% | 14.18% | 28.11% | 21.88% | Upgrade
|
| Cost of Revenue | 165.96 | 164.79 | 161.11 | 140.68 | 124.17 | 98.08 | Upgrade
|
| Gross Profit | 150.11 | 141.79 | 134.83 | 135.56 | 117.76 | 90.77 | Upgrade
|
| Selling, General & Admin | 104.22 | 100.65 | 111.06 | 144.37 | 132.32 | 96.5 | Upgrade
|
| Research & Development | 51.13 | 56.8 | 68.5 | 69.23 | 61.83 | 53.52 | Upgrade
|
| Operating Expenses | 203.24 | 198.89 | 221.78 | 261.89 | 231.68 | 168.74 | Upgrade
|
| Operating Income | -53.13 | -57.1 | -86.96 | -126.33 | -113.92 | -77.97 | Upgrade
|
| Interest Expense | -26.04 | -17.09 | -7.29 | -1.68 | - | -11.57 | Upgrade
|
| Interest & Investment Income | 11.47 | 17.98 | 16.39 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | 0.18 | -0.26 | 0 | - | -16.46 | - | Upgrade
|
| EBT Excluding Unusual Items | -67.52 | -56.46 | -77.85 | -128.01 | -130.38 | -89.54 | Upgrade
|
| Merger & Restructuring Charges | -10.54 | -12.15 | -14.58 | -13.32 | -7.89 | -2.67 | Upgrade
|
| Asset Writedown | -6.9 | -2.2 | -4.08 | -5.02 | -1.8 | - | Upgrade
|
| Legal Settlements | - | - | -21.28 | - | - | - | Upgrade
|
| Other Unusual Items | 7.06 | 1.64 | - | 4.67 | -20.04 | -24 | Upgrade
|
| Pretax Income | -106.66 | -69.17 | -117.79 | -141.68 | -160.11 | -116.21 | Upgrade
|
| Income Tax Expense | 0.96 | 0.33 | 0.36 | -4.28 | -6.9 | -1.19 | Upgrade
|
| Earnings From Continuing Operations | - | -69.5 | -118.15 | -137.4 | -153.21 | -115.02 | Upgrade
|
| Net Income | -107.62 | -69.5 | -118.15 | -137.4 | -153.21 | -115.02 | Upgrade
|
| Net Income to Common | -107.62 | -69.5 | -118.15 | -137.4 | -153.21 | -115.02 | Upgrade
|
| Shares Outstanding (Basic) | 68 | 60 | 56 | 54 | 47 | 40 | Upgrade
|
| Shares Outstanding (Diluted) | 68 | 60 | 56 | 54 | 47 | 40 | Upgrade
|
| Shares Change (YoY) | 14.90% | 6.68% | 4.32% | 13.87% | 20.12% | 110.98% | Upgrade
|
| EPS (Basic) | -1.59 | -1.15 | -2.09 | -2.56 | -3.23 | -2.91 | Upgrade
|
| EPS (Diluted) | -1.59 | -1.15 | -2.09 | -2.63 | -3.23 | -2.91 | Upgrade
|
| Free Cash Flow | -13.82 | 12.94 | -34.32 | -37.44 | -33.57 | -33.92 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | 0.21 | -0.61 | -0.69 | -0.71 | -0.86 | Upgrade
|
| Gross Margin | 47.49% | 46.25% | 45.56% | 49.07% | 48.68% | 48.07% | Upgrade
|
| Operating Margin | -16.81% | -18.62% | -29.38% | -45.73% | -47.09% | -41.29% | Upgrade
|
| Profit Margin | -34.05% | -22.67% | -39.92% | -49.74% | -63.33% | -60.91% | Upgrade
|
| Free Cash Flow Margin | -4.37% | 4.22% | -11.60% | -13.55% | -13.88% | -17.96% | Upgrade
|
| EBITDA | -16.85 | -25.37 | -53.24 | -84.83 | -78.79 | -59.94 | Upgrade
|
| EBITDA Margin | -5.33% | -8.27% | -17.99% | -30.71% | -32.57% | -31.74% | Upgrade
|
| D&A For EBITDA | 36.28 | 31.73 | 33.72 | 41.5 | 35.13 | 18.03 | Upgrade
|
| EBIT | -53.13 | -57.1 | -86.96 | -126.33 | -113.92 | -77.97 | Upgrade
|
| EBIT Margin | -16.81% | -18.62% | -29.38% | -45.73% | -47.09% | -41.29% | Upgrade
|
| Revenue as Reported | 316.06 | 306.58 | 295.94 | 276.24 | 241.93 | 188.85 | Upgrade
|
| Advertising Expenses | - | 5.1 | 2.6 | 5.7 | 4.4 | 4.3 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.